Dunhill Financial »

Regeneron Pharmaceuticals shares owned by Dunhill Financial

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Dunhill Financial from 13F filings

Historical chart of Dunhill Financial investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Dunhill Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Dunhill Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $141k 134 1052.93
2024-06-30 $130k 124 1047.55
2024-03-31 $11k 12 929.50
2023-12-31 $8.8k 10 884.30

More positions owned by Dunhill Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Long Term Treas (VGLT)
Ishares Tr Msci Kld400 Soc (DSI)
Pimco Etf Tr Active Bd Etf (BOND)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
First Tr Exchange-traded Buywrit Incm Etf (FTHI)
Vanguard Index Fds Small Cp Etf (VB)
Apple (AAPL)
Ishares Tr Esg Aw Msci Eafe (ESGD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
Pfizer (PFE)

View all positions for Dunhill Financial

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
FMR
Jpmorgan Chase & Co
State Street Corporation
Capital Research and Management Company - Division 3
Capital World Investors
Geode Capital Management
Dodge & Cox
T. Rowe Price Associates
Franklin Resources
Loomis, Sayles and
Amundi
Morgan Stanley
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals